Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, STAMPEDE Trial

Nicholas James

MD

🏢The Institute of Cancer Research🌐UK

Professor of Prostate and Bladder Cancer Research

68
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nicholas James at the ICR led the UK STAMPEDE trial — a landmark adaptive multi-arm multi-stage platform trial that has provided pivotal evidence for abiraterone, docetaxel, zoledronic acid, and multiple other treatments in metastatic hormone-sensitive prostate cancer. STAMPEDE's innovative design has set a new model for efficient clinical trial design in oncology.

Share:

🧪Research Fields 研究领域

prostate cancer
STAMPEDE trial
abiraterone mHSPC
metformin
UK prostate cancer research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Nicholas James 的研究动态

Follow Nicholas James's research updates

留下邮箱,当我们发布与 Nicholas James(The Institute of Cancer Research)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment